Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With Schizophrenia
NCT00654576 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1400
Last updated 2008-04-08
Summary
Antipsychotic alone is limit to improve the overall outcome of schizophrenia and has a high discontinue rate.To solve these problems, we provide practical and available psychosocial intervention. We hypothesize that there will be significant difference in the overall effectiveness between antipsychotic and antipsychotic combination with psychosocial intervention.
Conditions
Interventions
- DRUG
-
Chlorpromazine, Sulpiride, Clozapine, Olanzapine, Risperidone, Quetiapine, Aripitrazole
patient will receive one of the seven study drugs (Chlorpromazine, Sulpiride, Clozapine, Olanzapine, Risperidone, Quetiapine, Aripitrazole) as the maintain treatment. the dose is flexible, is based on the study doctor's judgment.
- BEHAVIORAL
-
psychosocial intervention
the psychosocial interventions include psychoeducaiton, family intervention, skill training, and cognitive-behavioral therapy.
Sponsors & Collaborators
-
Shanghai Mental Health Center
collaborator OTHER -
Sichuan University
collaborator OTHER -
Capital Medical University
collaborator OTHER -
Nanjing Medical University
collaborator OTHER -
Jiangxi Mental Hospital
collaborator UNKNOWN -
Hunan Mental Hospital
collaborator OTHER -
Guangzhou Mental Hospital
collaborator OTHER -
Chongqing Metal Institute
collaborator UNKNOWN -
Henan Mental Hospital
collaborator UNKNOWN -
Central South University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- FACTORIAL
Eligibility
- Min Age
- 16 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-02-28
- Primary Completion
- 2007-12-31
- Completion
- 2007-12-31
Countries
- China
Study Locations
More Related Trials
-
The Establishment of the Early Intervention Program for Patients With Schizophrenia
NCT00172770 ·Status: UNKNOWN
-
Long-Term Efficacy and Safety of Asenapine Using Haloperidol as a Positive Control (41513)(COMPLETED)(P05785)
NCT00156065 ·Status: COMPLETED ·Phase: PHASE3
-
Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-up
NCT02534363 ·Status: COMPLETED ·Phase: PHASE4
-
Early Pharmacological and Psychological Intervention for Late Prodromal States of Psychosis
NCT00204061 ·Status: COMPLETED ·Phase: PHASE4
-
Comparative Effectiveness of Adaptive Treatment Strategies for Schizophrenia
NCT02775864 ·Status: COMPLETED
-
The Effect of Paliperidone Palmitate in Schizophrenia
NCT01860781 ·Status: COMPLETED ·Phase: PHASE4
-
The Optimal Treatment for Treatment-resistant Schizophrenia
NCT02926976 ·Status: UNKNOWN ·Phase: NA
-
Peer-led Psycho-education for Schizophrenia
NCT03246932 ·Status: COMPLETED ·Phase: NA
-
The Effect of Psychosocial Skills Focused Group Psychoeducation in Schizophrenia Patients
NCT06872424 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Mindfulness-based Illness Management Program for Schizophrenia
NCT01667601 ·Status: COMPLETED ·Phase: NA
-
A 4-week, Randomized, Rater-blinded, Parallel Study to Evaluate Quetiapine in Improving Sleep Quality of Schizophrenia
NCT00642369 ·Status: COMPLETED ·Phase: NA
-
"Multimodal Prevention of Psychosis - Investigating Efficacy of N-Acetylcysteine and Psychotherapy in CHR-Patients"
NCT03149107 ·Status: TERMINATED ·Phase: PHASE3
-
Assessment of Efficacy of a Psychological Therapy in Inpatients With a Schizophrenic Psychosis
NCT03316664 ·Status: COMPLETED ·Phase: NA
-
Combination of NMDA-enhancing and Anti-inflammatory Treatments for Ultra-resistant Schizophrenia
NCT05240976 ·Status: RECRUITING ·Phase: PHASE2
-
Exploring the Effectiveness of Group Cognitive Stimulation Therapy in People With Schizophrenia.
NCT04916483 ·Status: UNKNOWN ·Phase: NA
-
A Study of Strategies to Improve Schizophrenia Treatment
NCT00156637 ·Status: COMPLETED ·Phase: NA
-
Recovery From Psychosis in Schizophrenia - The Impact of Cognitive-Behavioral Therapy
NCT00791440 ·Status: COMPLETED ·Phase: NA
-
Optimizing and Individualizing the Pharmacological Treatment of First-episode Schizophrenic Patients
NCT03451734 ·Status: COMPLETED
-
The Evaluation of Therapeutic Efficacy on the Integrated Group Psychotherapy for Patients With Schizophrenia
NCT01139099 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Family Group Interventions for People With Schizophrenia
NCT00940394 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Psychopharmacotherapy in Patients With Schizophrenia or Bipolar Disorders
NCT00330226 ·Status: UNKNOWN
-
Dual Modulation of Sigma-1 and NMDA Receptors in the Treatment of Schizophrenia
NCT06574360 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Asenapine With Placebo and Haloperidol (41023)(P05926)(COMPLETED)
NCT00156104 ·Status: COMPLETED ·Phase: PHASE3
-
Assertive Community Treatment With CBT and SST for Schizophrenia
NCT02254733 ·Status: COMPLETED ·Phase: NA
-
Shared Decision Making for Antipsychotic Medications
NCT05416658 ·Status: NOT_YET_RECRUITING ·Phase: NA